The BA.3.2 variant of COVID-19, also known as the Cicada variant, was first identified in South Africa in November 2024 and has since spread to at least 23 countries, including 25 states in the U.S. The variant carries approximately 70-75 mutations in the spike protein, raising concerns about its ability to evade immunity from prior infections and current vaccines.

Health experts are closely monitoring the situation. Brandon Dionne noted, “There definitely are quite a few mutations with this one, so there’s concern that the current vaccine is not going to be a great match.” Symptoms associated with BA.3.2 include sore throat, cough, congestion, fatigue, headache, fever, nausea, and diarrhea.

As of now, the CDC and WHO are actively tracking the variant’s spread. In the U.S., BA.3.2 was first detected in June 2025, and current vaccines are expected to provide some level of protection against it, although the exact effectiveness remains uncertain. Dr. Adolfo García-Sastre commented, “It’s not completely clear how effective the current vaccine will be, but it likely still has some effectiveness.”

Despite the alarming number of mutations, Andrew Pekosz stated, “It looks scary on paper, but it hasn’t really made a big impact in terms of disease in most places yet.” However, the variant’s emergence coincides with a troubling trend in the U.S., where COVID-19 is linked to 300-500 deaths per week.

Neil Maniar emphasized the importance of protecting high-risk individuals and continuing standard precautions, stating, “The biggest focus is really on protecting higher risk individuals and continuing standard precautions.”

Currently, 11 percent of wastewater samples in the U.S. contain BA.3.2, indicating its presence in communities. However, the exact prevalence of the variant remains unclear due to reduced surveillance efforts.

As health officials continue to monitor BA.3.2, uncertainties linger regarding its potential to evolve further and whether it will trigger a surge in cases. Details remain unconfirmed.

Сообщение Covid 19 cicada variant: COVID-19 Cicada Variant BA.3.2 Emerges in South Africa появились сначала на justrealnews.

The COVID variant BA.3.2, known as Cicada, is causing rising cases in the U.S. and globally, raising alarms among health officials. The variant, first detected in a traveler to the United States in June 2025, has since spread rapidly, with the first U.S. case diagnosed in January 2026.

As of February 11, 2026, BA.3.2 has been reported in at least 25 states across the U.S. and is responsible for approximately 30% of COVID-19 sequences in Germany and some Northern European countries. The World Health Organization classified BA.3.2 as a ‘variant under monitoring’ in December 2025, highlighting its potential impact.

BA.3.2 is characterized by a highly mutated spike protein, with 70-75 mutations identified. This raises concerns about its ability to evade immunity from previous infections or vaccinations. According to the CDC, “Monitoring the spread of BA.3.2 provides valuable information about the potential for this new SARS-CoV-2 lineage to evade immunity from a previous infection or vaccination.”

In the U.S., BA.3.2 has been detected in 3.7% of wastewater samples as of March 14, 2026, indicating its prevalence in communities. The variant has been reported in at least 23 countries, underscoring its global reach.

Despite the alarming statistics, experts like Dr. Andrew Pekosz emphasize that while BA.3.2 looks concerning on paper, it has not yet significantly impacted disease severity in most regions. However, Dr. Robert H. Hopkins, Jr. warns that low vaccination rates and insufficient public health measures leave the population vulnerable.

Current COVID vaccines are expected to continue providing protection against severe disease from BA.3.2, but the effectiveness of these vaccines against the variant is still being studied. As the situation evolves, health officials urge continued vigilance and vaccination efforts.

Details remain unconfirmed regarding the potential for BA.3.2 to cause a surge in cases in the U.S. Further developments are anticipated as researchers and health authorities monitor the variant closely.

Сообщение Cicada COVID Variant Causes Surge in Cases Across the U.S. появились сначала на justrealnews.

Before the emergence of long COVID, the expectation was that recovery from COVID-19 would be swift for most individuals. However, as the pandemic progressed, it became clear that a subset of patients experienced lingering symptoms long after their initial infection.

Recent data reveals a stark reality: as of December 2023, approximately one in five Canadian adults reported long-term symptoms following COVID-19 infection. In Newfoundland and Labrador specifically, 18.3 percent of adults self-reported long-term symptoms after testing positive between January 2020 and August 2022.

The direct effects of long COVID are profound. Patients often find themselves unable to engage in activities they once enjoyed, with some unable to complete 16-kilometre hikes they previously managed. Mike Hall, a local resident, shared his experience, stating, “She just never recovered,” highlighting the ongoing struggles faced by many.

Dr. Iram Anees, the only doctor in Newfoundland and Labrador specializing in long COVID, emphasizes the persistent nature of the condition, stating, “COVID is really unfortunately not over.” This sentiment reflects the ongoing challenges that individuals face as they navigate life with long COVID.

Health Canada has recognized long COVID as a disability, allowing affected individuals to be eligible for disability benefits. However, there remains a significant gap in treatment options, as there is currently no approved medication for long COVID.

In the search for potential treatments, a recent study examined the impact of vitamin D supplementation on long COVID outcomes. The VIVID Trial, which included 1,747 adults recently diagnosed with COVID-19, found that 21 percent of participants taking vitamin D reported lingering symptoms, compared to 25 percent in the placebo group. JoAnn Manson, MD, DrPH, noted, “While we didn’t find that high-dose vitamin D reduced COVID severity or hospitalizations, we observed a promising signal for long COVID that merits additional research.”

Long COVID can manifest in various ways, including fatigue, shortness of breath, and cognitive challenges, significantly impacting individuals’ lives. As the understanding of this condition evolves, the need for further research and effective treatments remains critical.

Details remain unconfirmed regarding the exact prevalence of long COVID symptoms in the general population, and the effectiveness of vitamin D supplementation is still under investigation. The ongoing exploration of long COVID highlights the need for continued attention and resources to support affected individuals.

Сообщение Covid long: Long COVID in Newfoundland and Labrador: A Growing Concern появились сначала на justrealnews.

The coronavirus pandemic has profoundly affected global health, economies, and daily life since its emergence in late 2019. As new variants and vaccination campaigns continue to shape the landscape, understanding the latest developments and preventive measures is essential for public health and safety.

Current Situation

As of October 2023, the World Health Organization (WHO) reports that several countries are experiencing localized spikes in COVID-19 cases, largely due to the emergence of new variants, such as Omicron sublineages. Countries like the United States, the United Kingdom, and parts of Asia are ramping up testing and vaccination efforts as they navigate these challenges.

Vaccination remains one of the most effective tools in combating the spread of the virus. The Centers for Disease Control and Prevention (CDC) highlights that booster shots, particularly for high-risk populations, are critical in mitigating severe cases and hospitalizations. Despite vaccine hesitancy in some regions, efforts to improve access and education are ongoing.

Preventive Measures and Recommendations

Health authorities continue to advocate for basic preventive measures, including mask-wearing in crowded places, maintaining social distance, and practicing good hand hygiene. Recent studies emphasize the importance of ventilation in indoor settings to reduce transmission. Public health campaigns are focused on encouraging vaccinations and promoting these strategies, especially as colder months approach and indoor gatherings increase.

Conclusion

With the coronavirus still posing a significant threat, continuous updates on the situation are vital. Experts urge the public to remain vigilant and adhere to health guidelines to protect themselves and their communities. The pandemic has highlighted the need for global cooperation in health responses and preparedness for future outbreaks. Staying informed through reliable sources will empower individuals to make informed decisions about their health and safety.

Сообщение Understanding the Ongoing Coronavirus Pandemic появились сначала на justrealnews.